Clinical studies recruiting near Suwon

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · Ajou University Medical Center · Eisai Korea Inc. · NCT06246123 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital · Pfizer · NCT06758401 Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Ajou University Hospital · Walden Biosciences · NCT06466135 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Ajou University Hospital · Boehringer Ingelheim · NCT07355296 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 4100002 · Sanofi · NCT07190196 Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
Phase 2 · The Catholic University of Korea, St. Vincent's Hospital · NeuroBiogen Co., Ltd · NCT07009171 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital · Eli Lilly and Company · NCT06890598 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · St. Vincent Hospital - The Catholic University of Korea · Regeneron Pharmaceuticals · NCT06091865 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Catholic University of Korea Saint Vincent's Hospital · Fore Biotherapeutics · NCT05503797 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Ajou University Hospital · Pfizer · NCT05895786 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital-Medi · Merck Sharp & Dohme LLC · NCT06077760 Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
Phase 3 · Ajou University Hospital · National Cancer Center, Korea · NCT05827523 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Ajou University Hospital · Biogen · NCT06962800 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Ajou University Hospital · Boehringer Ingelheim · NCT07220083 Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Phase 1 · Ajou University Medical Center · GC Biopharma Corp · NCT06567769 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Ajou University Hospital · Eli Lilly and Company · NCT06338995 South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
NA · Ajou University Hospital · Seong Hye Choi, MD · NCT06891573 Comparison of PROVISIONal 1-stent Strategy with DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
NA · St. Vincent's Hospital , the Catholic University · Saint Vincent's Hospital, Korea · NCT06002932 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · The Catholic University of Korea St. Vincent s Hospital ( Si · Merck Sharp & Dohme LLC · NCT06623422 Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagog
Phase 2 · Ajou University Hospital · National Cancer Center, Japan · NCT07699939 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Ajou University Hospital-Primary Research Location · Takeda · NCT06963827 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · Saint Vincent's Hospital · Taiho Oncology, Inc. · NCT05967689 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital /ID# · AbbVie · NCT04928846 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0207 · Bristol-Myers Squibb · NCT03899155 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · The Catholic University Of Korea St. Vincent's Hospital /ID# · AbbVie · NCT07525206 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · The Catholic University of Korea, St Vincents Hospital · BeOne Medicines · NCT07492641

Look up another city

Look up another condition